

Publisher: Bentham Science Publishers
E-ISSN: 1873-5592|12|14|2079-2090
ISSN: 1389-4501
Source: Current Drug Targets, Vol.12, Iss.14, 2011-12, pp. : 2079-2090
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Pharmacometrics of Stilbenes: Seguing Towards the Clinic
Current Clinical Pharmacology, Vol. 1, Iss. 1, 2006-01 ,pp. :


Targeting liver X receptors in human health: deadlock or promising trail?
By Viennois Emilie Pommier Aurélien JC Mouzat Kévin Oumeddour Abdelkader Hajjaji Fatim-Zohra El Dufour Julie Caira Françoise Volle David H Baron Silvère Lobaccaro Jean-Marc A
Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 2, 2011-02 ,pp. :



